A <i>POLR1D</i>-regulating single-nucleotide polymorphism as a predictive marker candidate for platinum-based chemotherapy in gastrointestinal cancers.

Ther Adv Med Oncol · 2025 · PMC12256759 · PMID 40661991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results indicated that the cases with absent POLR1D expression showed a trend toward a response to neoadjuvant ChT or pathological complete response with odds ratios of 4.950 and 2.708, respectively.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A &lt;i&gt;POLR1D&lt;/i&gt;-regulating single-nucleotide polymorphism as a predictive marker candidate for platinum-based chemotherapy in gastrointestinal cancers.

The sentences

A <i>POLR1D</i>-regulating single-nucleotide polymorphism as a predictive marker candidate for platinum-based chemotherapy in gastrointestinal cancers.